Our results showed a decrease in the expression of the activating receptor NKp46 in melanoma-bearing mice (p < 0.01) compared to healthy mice, while the ALDARA treatment induced an increase in NK1.1+NKp46+ cells compared to the MbM group (p < 0.001) (Figure 3a). This evidence concerns the gene NCR1 and melanoma.